Prominent PRO Medical Researcher and Bio-IT World Editor-in-Chief to Keynote PHT’s 6th Annual ePRO Conference and User Group Meeting

PHT Corporation, the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 360 clinical trials worldwide, will gather pharmaceutical and biotechnology industry thought leaders for its comprehensive ePRO and eClinical meeting October 15-17 in historic Salem, MA. The User Group Meeting and Conference will feature keynote speakers Ethan Basch, MD, MSc. and Bio-IT World editor-in-chief Kevin Davies, PhD.

Dr. Ethan Basch is a medical oncologist at Memorial Sloan-Kettering Cancer Center who conducts research on applications of PROs in cancer clinical trials and routine care. This work focuses on methods to improve data quality and safety through the development of standards for adverse symptom event monitoring and reporting. This research is conducted in collaboration with stakeholders at the National Cancer Institute and FDA, where he serves as a guest member of the Study Endpoints and Labeling Design team (SEALD). Current projects include a national trial of patient-reported adverse symptoms in the NCI cooperative group setting, and a large randomized study of patient self-reporting. In his practice, Dr. Basch sees patients with prostate cancer. Dr. Basch is a graduate of Harvard Medical School and Harvard School of Public Health. For PHT’s User Group Meeting and Conference, Dr. Basch will provide a keynote presentation on the use of PROs for adverse symptom monitoring in oncology.

Dr. Kevin Davies is the founding editor of Bio-IT World magazine and author of “Cracking the Genome: Inside the Race to Unlock Human DNA.” Dr. Davies is a molecular geneticist by training and continues scientific publishing and thought-leadership in the field. Before working at Bio-IT World, he was the editor-in-chief of Cell Press and the founder of Nature Genetics. Dr. Davies has written for numerous magazines and books and founded multiple scientific publications. Dr. Davies is a graduate of Oxford University and the University of London, and conducted research at the Whitehead Institute and Harvard Medical School. Dr. Davies will discuss emerging trends in personal genomic research and their impact on the pharmaceutical industry in his keynote presentation at PHT’s User Group Meeting and Conference.

In addition to presentations by Drs. Basch and Davies, industry leaders and other clinical research leaders will present informative case studies on pertinent topics such as FDA audits, PRO validation, adaptive trials and the site perspective at the meeting.

Registration is open at www.phtcorp.com/UGM2008. For more information, contact PHT’s Christina Curry, Marketing Specialist, at 617-973-1794 or ccurry@phtcorp.com.

About PHT Corporation

Trust your patient and questionnaire data again. PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 360 clinical trials by 90 biopharmaceutical clients. The proven LogPad(R) System and revolutionary SitePad(TM) Tablet deliver the voice of the patient, in 80 languages, from homes and sites in 60 countries around the world. By capturing high-quality and time stamped assessments with minimal respondent burden, transmitted over reliable analog and wireless global technologies, sponsors are able to run smaller and more conclusive clinical research programs. Real-time study management through PHT StudyWorks(TM) features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO(TM) email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least seven known NDA approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Clinical research representatives from past and present PHT clients can see more details and register online at www.regonline.com/UGM2008.

 Media contact: Brenda Nashawaty Email Contact 617-688-3253  

SOURCE: PHT Corporation